D
Daniel M. Doleys
Researcher at Royal North Shore Hospital
Publications - 15
Citations - 735
Daniel M. Doleys is an academic researcher from Royal North Shore Hospital. The author has contributed to research in topics: Chronic pain & Prospective cohort study. The author has an hindex of 10, co-authored 15 publications receiving 612 citations.
Papers
More filters
Journal ArticleDOI
The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines
Timothy R. Deer,Jason E. Pope,Salim M. Hayek,Anjum Bux,Eric Buchser,Sam Eldabe,Jose De Andres,Michael A. Erdek,Dennis Patin,Jay S. Grider,Daniel M. Doleys,Marilyn S. Jacobs,Tony L. Yaksh,Lawrence Poree,Mark S. Wallace,Joshua P. Prager,Richard Rauck,Oscar DeLeon,Sudhir Diwan,Steven M. Falowski,Helena M. Gazelka,Philip Kim,Philip Kim,Michael S. Leong,Robert M. Levy,Gladstone C. McDowell,Porter McRoberts,Ramana K. Naidu,Samir Narouze,Christophe Perruchoud,Steven M. Rosen,William S. Rosenberg,Michael Saulino,Peter S. Staats,Lisa Stearns,Dean Willis,Elliot S. Krames,Marc A. Huntoon,Nagy Mekhail +38 more
TL;DR: Pain treatment is best performed when a patient‐centric, safety‐based philosophy is used to determine an algorithmic process to guide care.
Journal ArticleDOI
Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain
Timothy R. Deer,Howard S. Smith,Allen W. Burton,Jason E. Pope,Daniel M. Doleys,Robert M. Levy,Peter S. Staats,Mark S. Wallace,Lynn R. Webster,Richard Rauck,Michael Cousins +10 more
TL;DR: In this paper, the authors outline consensus guidelines for the implementation of intrathecal therapy in patients with cancer-related pain and other end-of-life states causing pain, including individuals at the end of life from a variety of causes.
Journal ArticleDOI
Consensus Guidelines for the Selection and Implantation of Patients With Noncancer Pain for Intrathecal Drug Delivery
Timothy R. Deer,Howard S. Smith,Michael J. Cousins,Daniel M. Doleys,Robert M. Levy,James P. Rathmell,Peter S. Staats,Mark S. Wallace,Lynn R. Webster +8 more
TL;DR: These consensus guidelines are intended to assist with weighing this risk/benefit ratio of intrathecal therapy, thereby minimizing the potential for treatment failure, unacceptable adverse effects, and excess mortality.
Journal ArticleDOI
Prospective Study of 3-Year Follow-Up of Low-Dose Intrathecal Opioids in the Management of Chronic Nonmalignant Pain
Maged Hamza,Daniel M. Doleys,Mary Wells,Jackie Weisbein,Jeremy Hoff,Michelle Martin,Costa Soteropoulos,Jose Barreto,Steven Deschner,Jessica M. Ketchum +9 more
TL;DR: Low-dose IT opioid can provide sustained significant improvement in pain and function for long-term follow-up in chronic noncancer pain.
Journal ArticleDOI
The Polyanalgesic Consensus Conference (PACC): Recommendations for Trialing of Intrathecal Drug Delivery Infusion Therapy.
Timothy R. Deer,Salim M. Hayek,Jason E. Pope,Tim J. Lamer,Maged Hamza,Jay S. Grider,Steven M. Rosen,Samir Narouze,Christophe Perruchoud,Simon Thomson,Marc Russo,Eric Grigsby,Daniel M. Doleys,Marilyn S. Jacobs,Michael Saulino,Paul J. Christo,Philip Kim,Philip Kim,Elliot Marc Huntoon,Elliot S. Krames,Nagy Mekhail +20 more
TL;DR: A consensus on best practices for determining appropriate use of IT drug infusion may involve testing/trialing this therapy before implantation.